Zaman F, Gieser SC, Schwartz GF, Swan C, Williams JM. A multicenter, open-label study
of
netarsudil
for the reduction of elevated intraocular pressure in patients with open-angle
glaucoma
or
ocular
hypertension in a real-world setting. Curr Med Res Opin. 2021;37(6):1011-1020
